Claude Bernard Lyon 1 University (UCBL) offers its 46,000 students high-quality programs in the fields of Science and Technology, Health, and Sports Sciences. In addition to its teaching activities, UCBL hosts 62 research units across three major sectors: Science and Technology, Life and Environmental Sciences, and Human and Social Sciences. As the leading French university in patent filings and with 7,000 research articles published in 2022, UCBL is a major hub for academic research in France.
The Lyon Cancer Research Center (CRCL) is a cancer research institute accredited by UCBL, Inserm (UMR Inserm 1052), CNRS (CNRS 5286), and the Léon Bérard Center (CLB), with the Hospices Civils de Lyon (HCL) as its hospital partner. The CRCL opened in January 2011 with the aim of increasing the site’s international recognition and attractiveness, facilitating the transfer of knowledge to clinical practice and industry, and promoting education and training. The CRCL consists of 26 research teams, bringing together more than 600 staff members, including 150 researchers.
UCBL teams involved in SyStInn RHU project
- Oncopharmacology Team:
Pr. Charles DUMONTET, Abdelkamel CHETTAB, Dr. Laury-Anne LEROY-CHATELAIN, Sabine BEAUMEL, Eva-Laure MATERA, Dr. Juliette HUMEAU, Louise MAHE, Clémence GROSJEAN - Cell death and Childhood cancer Team:
Dr. Aurélie DUTOUR, Mathias RABY - Cancer Immune Surveillance and Therapeutic Targeting:
Dr. Christophe CAUX
Support provided by Lyon Ingénierie Projets (LIP), an innovation consulting firm specializing in the development and management of collaborative projects:
- Business Development Manager: Dr. Vanessa PADUANO
- Legal Affairs Manager: Françoise RIMAILHO
UCBL Scientific and Technical Manager,
RHU leader
Pr. Charles DUMONTET,
Deputy Director and Head of the Oncopharmacology Team at the Lyon Cancer Research Center (CRCL) & Professor of Hematology at UCBL
